Strata Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$301K Buy
10,544
+260
+3% +$6.92K 0.07% 77
2026
Q2
$248K Sell
10,284
-716
-7% -$18.7K 0.06% 86
2026
Q1
$309K Buy
11,000
+639
+6% +$17K 0.08% 71
2025
Q4
$258K Sell
10,361
-277
-3% -$6.98K 0.07% 79
2025
Q3
$271K Sell
10,638
-54
-0.5% -$1.33K 0.07% 84
2025
Q2
$259K Buy
+10,692
New +$249K 0.07% 68
2025
Q1
– Sell
-15,162
Closed -$402K – 75
2024
Q4
$402K Buy
15,162
+3,897
+35% +$106K 0.13% 55
2024
Q3
$326K Buy
+11,265
New +$329K 0.1% 58

Other funds holding PFE

Strata Wealth Advisors's PFE Position: Q3 2026 in Review

Strata Wealth Advisors increased its Pfizer (PFE) stake by 2.5% in Q3 2026, buying an estimated $6.92K and bringing the position to 10,544 shares worth $301K. The position accounts for 0.07% of the portfolio, ranked #77.

Strata Wealth Advisors first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $402K in Q4 2024. 681 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Strata Wealth Advisors held 10,544 shares of Pfizer worth $301K as of Q3 2026.
  • Strata Wealth Advisors bought 260 Pfizer shares in Q3 2026, an estimated $6.92K.
  • Pfizer made up 0.07% of Strata Wealth Advisors's portfolio in Q3 2026, its #77 holding.
  • Strata Wealth Advisors first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • Strata Wealth Advisors's Pfizer position peaked at $402K in Q4 2024.
  • 681 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Strata Wealth Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.